(Q44287731)

1 December 2017

title

Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial (English)

1 reference

1 December 2017

1 reference

1 reference

1 reference

1 December 2017

Melchart D

1 reference

1 December 2017

Thormaehlen J

1 reference

1 December 2017

Hager S

1 reference

1 December 2017

Liao J

1 reference

1 December 2017

Weidenhammer W

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of Internal Medicine

1 December 2017

published in

1 reference

1 December 2017

volume

253

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

181-188

1 reference

Complementary medicine: use and attitudes among GPs.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Acupuncture for recurrent headaches: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Introducing a placebo needle into acupuncture research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Treatment of Acute Migraine With Subcutaneous Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01081.X

10.1046/J.1365-2796.2003.01081.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference